Hrt Financial LP Neogenomics Inc Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$12.15 - $17.85 $78,051 - $114,668	-6,424 Reduced 36.28%	11,285 $138,000
Q2 2023 Aug 11, 2023	SELL	$14.1 - $19.83 $2.48 Million - $3.49 Million	-175,944 Reduced 90.86%	17,709 $284,000
Q1 2023 May 12, 2023	BUY	$9.09 - $19.45 $1.76 Million - $3.77 Million	193,653 New	193,653 $3.37 Million
Q1 2022 May 16, 2022	SELL	$12.15 - $35.28 $653,305 - $1.9 Million	-53,770 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $1.64 Million - $2.61 Million	53,770 New	53,770 $1.83 Million

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.13B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.